17th World ADC San Diego Leaderboard
  • Thursday, May 14, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Obesity & Weight Loss Drug Development Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 351

Author

Pharma Journalist 8791 posts 0 comments

Key Topics for SMi’s Ophthalmic Drugs Conference Released

Jul 1, 2021
SMi Group reports: Hear from industry experts at the 4th annual Ophthalmic Drugs Conference convening on 22nd & 23rd November 2021 in London. The Ophthalmic Drugs conference will…
Read More...

Medical Device regulations: strategies for compliance

Jul 1, 2021
SMi Group reports: Medical Devices and IVD Conference 2021 which will convene on 15th and 16th November 2021 in London. Join Europe’s leading Medical Device and IVD Conference which…
Read More...

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

Jun 30, 2021
OnCusp Therapeutics a global biopharmaceutical company focused on translating cutting-edge research assets into innovative oncology therapeutics, announced that it has officially…
Read More...

Gavi signs agreement with Clover Biopharmaceuticals for supply to COVAX

Jun 30, 2021
Gavi, the Vaccine Alliance announced that it had signed an advance purchase agreement (APA) with Clover Biopharmaceuticals for its SCB-2019 protein-based adjuvanted vaccine candidate…
Read More...

Altimmune Announces Update On AdCOVID Phase 1 Clinical Trial

Jun 30, 2021
Altimmune, Inc. a clinical-stage biopharmaceutical company, today provided an update on its AdCOVID investigational vaccine for the prevention of COVID-19. The Company also provided an…
Read More...

$850 Million USD (¥90 Billion Yen) investment in FUJIFILM Diosynth Biotechnologies to add additional…

Jun 30, 2021
FUJIFILM Corporation announced a ¥90 Billion Yen (~$850 Million USD) investment package to accelerate the growth of its core Bio CDMO subsidiary, FUJIFILM Diosynth Biotechnologies.…
Read More...

Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim

Jun 30, 2021
Aragen Life Sciences (formerly GVK BIO), a leading Contract Research and Development Organization, headquartered out of Hyderabad, India, announces an expansion of their discovery…
Read More...

Prilenia receives positive EMA opinion on Orphan Drug Designation for pridopidine in ALS

Jun 30, 2021
Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, received a positive opinion…
Read More...

Virtual events attract more new visitors

Jun 30, 2021
A recent report by the International Pharmaceutical Congress Advisory Association (IPCAA) and Ashfield Meetings & Events found an interesting conclusion: 92% of Health Care…
Read More...

RedHill Biopharma’s Opaganib Inhibits COVID-19 Variants in Preclinical Study

Jun 29, 2021
RedHill Biopharma Ltd. a specialty biopharmaceutical company, today announced preliminary results of a new preclinical study showing potent inhibition of COVID-19 variants of concern by…
Read More...
Prev Next
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
5th World ADC Summit South Korea
Extrahepatic Lipid-Based Nanoparticles Delivery Summit
World TPD & Induced Proximity Summit South Korea
Investigative & Preclinical Toxicology Summit 2026
LEAP HR: Life Sciences West
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
R&D Procurement & Sourcing in Pharma Summit
In Vivo Cell Engineering & Gene Editing Summit
PFS & Injectable Drug Delivery West Coast
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
World Bispecific & T-Cell Engager Summit South Korea
TCR-Based Therapies Summit
Nasal Formulation & Delivery Summit
ALS Drug Development Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • World ADC San Diego Unveils Preliminary Agenda for 17th Annual Meeting
  • GSK Partners With Sino Biopharmaceutical on Hepatitis B Drug
  • EU Approves Sotyktu for Psoriatic Arthritis
  • FDA Seeks Public Input on Drug Repurposing Efforts
  • FDA Approves BIZENGRI for NRG1+ Cholangiocarcinoma

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

Turning Biophysical Data into Confident Drug Discovery…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.